or Try an Advanced Search...

    Technical Analysis for NOTV - Inotiv, Inc.

    Grade Last Price % Change Price Change
    F 1.93 -9.81% -0.21
    NOTV closed down 9.81 percent on Friday, May 17, 2024, on 1.27 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical NOTV trend table...
    Date Alert Name Type % Chg
    180 Bearish Setup Bearish Swing Setup 0.00%
    Calm After Storm Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Below Lower BB Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Calm After Storm Range Contraction -9.81%
    Narrow Range Bar Range Contraction -9.81%
    Older End-of-Day Signals for NOTV ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown 1 day ago
    Down 10% 1 day ago
    Rose Above Lower Bollinger Band 1 day ago
    Down 5% 1 day ago
    Down 3% 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    NOTV Chart by TradingView
    Basic chart:

    Profile

    Inotiv, Inc. is a pharmaceutical development company providing contract research services and monitoring instruments to emerging pharmaceutical companies and the world's leading drug development companies and medical research organizations. The Company focuses on developing innovative services supporting its clients’ discovery and development objectives for improved decision-making and accelerated goal attainment. The Company’s products focus on increasing efficiency, improving data, and reducing the cost of taking new drugs to market.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Pharmaceutical Health Sciences Pharmacy Health Care Pharmacology Drug Development Pharmaceutical Sciences Contract Research Organizations Contract Research Services

    Is NOTV a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 16 Inotiv, Inc. (NOTV) Q2 2024 Earnings Call Transcript
    May 15 Inotiv GAAP EPS of -$1.86 misses by $1.32, revenue of $119M misses by $14.08M
    May 15 Inotiv Reports Second Quarter Financial Results for Fiscal 2024 and Provides Business Update
    May 14 Inotiv tumbles 50% on revenue outlook, business update
    May 14 Inotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Wednesday, May 15, 2024
    May 9 Inotiv, Inc. Reschedules its Fiscal 2024 Second Quarter Results
    May 9 Inotiv Q2 2024 Earnings Preview
    May 2 Investors push Inotiv (NASDAQ:NOTV) 16% lower this week, company's increasing losses might be to blame
    Apr 29 Inotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Friday, May 10, 2024
    Apr 4 Inotiv Stock: Financial Turnaround Overshadowed By Animal Testing Controversies
    See more NOTV news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.4166
    52 Week Low 1.61
    Average Volume 596,928
    200-Day Moving Average 4.31
    50-Day Moving Average 6.43
    20-Day Moving Average 3.85
    10-Day Moving Average 3.48
    Average True Range 0.61
    RSI (14) 25.93
    ADX 33.03
    +DI 14.61
    -DI 42.20
    Chandelier Exit (Long, 3 ATRs) 3.51
    Chandelier Exit (Short, 3 ATRs) 3.56
    Upper Bollinger Bands 5.71
    Lower Bollinger Band 1.99
    Percent B (%b) -0.02
    BandWidth 96.73
    MACD Line -1.03
    MACD Signal Line -0.89
    MACD Histogram -0.1339
    Fundamentals Value
    Market Cap 49.78 Million
    Num Shares 25.8 Million
    EPS -1.29
    Price-to-Earnings (P/E) Ratio -1.50
    Price-to-Sales 0.24
    Price-to-Book 0.44
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.33
    Resistance 3 (R3) 2.35 2.24 2.26
    Resistance 2 (R2) 2.24 2.14 2.23 2.24
    Resistance 1 (R1) 2.09 2.08 2.03 2.06 2.22
    Pivot Point 1.98 1.98 1.95 1.96 1.98
    Support 1 (S1) 1.82 1.87 1.77 1.80 1.64
    Support 2 (S2) 1.71 1.81 1.70 1.62
    Support 3 (S3) 1.56 1.71 1.60
    Support 4 (S4) 1.53